Narinx J, Servais S, Baron F, Beguin Y, Willems E
Service d'Hématologie, CHU de Liège et CHR de la Citadelle, Liège, Belgique.
Rev Med Liege. 2021 May;76(5-6):464-469.
Hematopoietic stem cell transplantation is a potentially curative therapeutic option for many oncologic and non-oncologic hematological diseases. There is a constant evolution regarding donor choice, conditioning regimen intensity and immunosuppressive treatments, which leads to a reduction in morbidity and mortality during and after transplantation. In this article, we describe the general principles of hematopoietic stem cell transplantation and discuss the progress of global patient management after transplantation.
造血干细胞移植是许多肿瘤性和非肿瘤性血液疾病潜在的治愈性治疗选择。在供体选择、预处理方案强度和免疫抑制治疗方面不断发展,这使得移植期间及移植后的发病率和死亡率有所降低。在本文中,我们描述了造血干细胞移植的一般原则,并讨论了全球移植后患者管理的进展。